← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 20, 2019Last known activity
Dec 30, 2025
Timeline
2010s
- Apr 1, 2016
Abbisko Therapeutics Co, Ltd— Founded
Drugs by trial phase (20 distinct, 32 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Recent trials (35)
- NCT06668103Lead sponsorPhase 2Dec 30, 2025
- NCT07297875Lead sponsorPhase 1/Phase 2Dec 10, 2025
- NCT07010497CollaboratorPhase 2Nov 14, 2025
- NCT07164170Lead sponsorPhase 2Oct 25, 2025
- NCT07210996Lead sponsorPhase 1Sep 12, 2025
- NCT07288957Lead sponsorPhase 1Jul 22, 2025
- NCT07007546Lead sponsorPhase 1May 17, 2025
- NCT07126249Lead sponsorPhase 1May 13, 2025
- NCT06884072Lead sponsorPhase 1Apr 8, 2025
- NCT06896760Lead sponsorPhase 1Apr 7, 2025
- NCT06779253Lead sponsorPhase 1Mar 20, 2025
- NCT06694948Lead sponsorPhase 1Dec 28, 2024
- NCT06632262Lead sponsorPhase 2Nov 13, 2024
- NCT06322706Lead sponsorPhase 1Mar 28, 2024
- NCT06306872Lead sponsorPhase 1Feb 23, 2024
Details
- Founded
- Shanghai, CN Apr 1, 2016
- Last known activity
- Dec 30, 2025